Kallikrein-4 (155-169)

Kallikrein-4

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-360

Synonyms/Alias:Kallikrein-4 (155-169)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
LLANGRMPTVLQCVN
Areas of Interest
Antigen-presenting Cells; Cancer Research

Kallikrein-4 (155-169) is a synthetic peptide fragment derived from the human kallikrein-4 protein, a member of the tissue kallikrein family of serine proteases. This peptide represents a defined sequence within the C-terminal region of kallikrein-4, which is implicated in various physiological and pathological processes, including extracellular matrix remodeling, cell signaling, and proteolytic cascades. Due to its well-characterized amino acid sequence and relevance to protease biology, Kallikrein-4 (155-169) serves as a valuable tool in biochemical research focused on understanding substrate specificity, protein-protein interactions, and regulatory mechanisms involving kallikrein family members.

Enzymology studies: Researchers employ this peptide fragment in enzymology assays to investigate the substrate recognition and cleavage specificity of kallikrein-4 and related serine proteases. By providing a defined substrate or competitive inhibitor, the peptide allows detailed kinetic analyses and mapping of active site preferences, contributing to a deeper understanding of proteolytic activity and regulation within the kallikrein family.

Protease inhibitor screening: The peptide is frequently utilized in high-throughput screening platforms designed to identify and characterize inhibitors of kallikrein-4 activity. Through monitoring the hydrolysis or binding of the peptide sequence, scientists can evaluate the efficacy and selectivity of candidate inhibitors, advancing the discovery of novel modulators for biochemical and pharmacological research.

Protein interaction mapping: Kallikrein-4 (155-169) is valuable in studies aimed at elucidating protein-protein interaction networks involving kallikrein-4. By serving as a molecular probe, the peptide facilitates affinity-based assays such as pull-downs or surface plasmon resonance, enabling the identification of binding partners and interaction domains relevant to extracellular matrix dynamics and cell signaling pathways.

Antibody development and validation: Synthetic peptides corresponding to unique protein regions are widely employed as immunogens or assay standards in antibody production. The defined sequence of this peptide fragment supports the generation and validation of highly specific antibodies against kallikrein-4, which are essential for immunodetection, quantification, and localization studies in tissue samples or cell lysates.

Mass spectrometry calibration: The peptide's precise amino acid composition makes it an ideal standard for calibrating and validating mass spectrometry-based proteomic workflows. By incorporating Kallikrein-4 (155-169) as a reference or spike-in control, researchers can ensure accurate mass determination, optimize peptide fragmentation parameters, and improve the reliability of protein identification and quantification in complex biological samples.

Source#
Homo sapiens (human)
Epitope
155-169
Restricting HLA
HLA-DR4
References
Hural; J Immunol 2002

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Synthesis ServicesEpitope Mapping ServicesPeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide CDMOCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers